Clinical significance of concomitant bacteriuria in patients with Staphylococcus aureus bacteraemia.
Fiche du document
- doi: 10.1007/s10096-023-04559-z
- issn: 0934-9723
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1007/s10096-023-04559-z
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/36725816
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/1435-4373
Ce document est lié à :
info:eu-repo/grantAgreement/UNIL/////
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_1DBF56EE5F6D1
info:eu-repo/semantics/openAccess , CC BY 4.0 , https://creativecommons.org/licenses/by/4.0/
Sujets proches
Bacteriemia BacteraemiaCiter ce document
M. Papadimitriou-Olivgeris et al., « Clinical significance of concomitant bacteriuria in patients with Staphylococcus aureus bacteraemia. », Serveur académique Lausannois, ID : 10.1007/s10096-023-04559-z
Métriques
Partage / Export
Résumé
This retrospective study, conducted at Lausanne University Hospital (2015-2021), compared Staphylococcus aureus bacteraemia (SABA) patients with or without concomitant bacteriuria (SABU). Among 448 included bacteraemic patients, 62 (13.8%) had S. aureus concurrently isolated from urine. In multivariate analysis, there was a significant difference in the odds of community-onset bacteraemia (P 0.030), malignancy (P 0.002), > 1 pair of positive blood cultures (P 0.037), and persistent bacteraemia for at least 48 h (P 0.045) in patients with concurrent SABU. No difference concerning mortality was found. On the other hand, SABU was associated with higher rates of SABA recurrence after antibiotic cessation.